Defitelio and Foscavir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Defitelio and Foscavir. Common interactions include cholestasis among females and acute respiratory distress syndrome among males.

The phase IV clinical study analyzes what interactions people who take Defitelio and Foscavir have. It is created by eHealthMe based on reports of 25 people who take Defitelio and Foscavir from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Jan, 25, 2023

25 people who take Defitelio and Foscavir together, and have interactions are studied.


What is Defitelio?

Defitelio has active ingredients of defibrotide sodium. eHealthMe is studying from 3,105 Defitelio users for its effectiveness, alternative drugs and more.

What is Foscavir?

Foscavir has active ingredients of foscarnet sodium. eHealthMe is studying from 1,548 Foscavir users for its effectiveness, alternative drugs and more.

Number of Defitelio and Foscavir reports submitted per year:

Defitelio and Foscavir drug interactions.

Common Defitelio and Foscavir drug interactions by gender *:

female:

  1. Cholestasis
  2. Drug ineffective
  3. Hepatitis a
  4. Intermenstrual bleeding
  5. Pulmonary toxicity
  6. Venoocclusive disease
  7. Acute respiratory distress syndrome
  8. Colitis
  9. Death
  10. Disease progression

male:

  1. Acute respiratory distress syndrome
  2. Graft versus host disease
  3. Platelet count decreased
  4. Renal impairment
  5. Subarachnoid haemorrhage
  6. Bone marrow failure
  7. Staphylococcal sepsis
  8. Pneumonia
  9. Cerebral haemorrhage

Common Defitelio and Foscavir drug interactions by age *:

0-1:

n/a

2-9:

  1. Acute respiratory distress syndrome
  2. Colitis
  3. Gastritis
  4. Melaena
  5. Overdose
  6. Pericardial effusion

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Venoocclusive disease
  2. Pneumonia
  3. Bone marrow failure
  4. Death
  5. Disease progression
  6. Graft versus host disease
  7. Renal impairment
  8. Acute respiratory distress syndrome
  9. Cerebral haemorrhage
  10. Cholestasis

60+:

  1. Platelet count decreased
  2. Subarachnoid haemorrhage
  3. Staphylococcal sepsis

Common conditions people have *:

  1. Venoocclusive Liver Disease (small veins in the liver are obstructed): 18 people, 72.00%
  2. Fever: 9 people, 36.00%
  3. Sepsis (a severe blood infection that can lead to organ failure and death): 7 people, 28.00%
  4. Pulmonary Veno-Occlusive Disease (obstructive disease of the pulmonary veins): 7 people, 28.00%
  5. Disease Recurrence: 7 people, 28.00%
  6. Diarrhea: 7 people, 28.00%
  7. Venoocclusive Disease (small veins in the liver are obstructed): 5 people, 20.00%
  8. Cytomegalovirus Infection: 5 people, 20.00%
  9. Staphylococcal Infection (an infection with staphylococcus bacteria): 2 people, 8.00%
  10. Pneumonia: 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Defitelio and Foscavir?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Defitelio and Foscavir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Defitelio side effects:

Browse all side effects of Defitelio:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Foscavir side effects:

Browse all side effects of Foscavir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Defitelio interactions:

Browse all interactions between Defitelio and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Foscavir interactions:

Browse all interactions between Foscavir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on defibrotide sodium and foscarnet sodium (the active ingredients of Defitelio and Foscavir, respectively), and Defitelio and Foscavir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Defitelio and Foscavir.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: